Why Azenta Stock Crushed it on Wednesday
Azenta (AZTA) Following Earnings And Deals Has Its Valuation Story Changed
Azenta Inc (AZTA) (Q4 2026) Earnings Call Highlights: Revenue Tops Guidance as Gene Synthesis ...
Azenta (AZTA) Q4 2026 Earnings Call Transcript
What Azenta (AZTA) Said on Its Q4 Earnings Call
Jefferies Maintains Buy on Azenta, Raises Price Target to $52
Azenta, Inc. Q4 2026 Earnings Call Summary
Azenta, Inc. (AZTA) Q4 2026 Earnings Call Transcript
Azenta, Inc. 2026 Q4 - Results - Earnings Call Presentation
Azenta (NASDAQ:AZTA) Q4 Earnings Beat Revenue and EPS Consensus, Shares Rise After Hours
Azenta (NASDAQ:AZTA) reports upbeat Q3 CY2026, stock jumps 10.3%
Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026.
Azenta Sees FY2027 Sales $648.000M-$660.000M vs $639.051M Est
Azenta Q4 Adj. EPS $0.28 Beats $0.11 Estimate, Sales $167.088M Beat $160.133M Estimate
Azenta: A Sample Custody Annuity Priced Like A Broken Equipment Vendor
Azenta Stock Outlook After DNA Technology Deal
Azenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities
Azenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast
Azenta (AZTA) Could Be 14% Below Fair Value Following Margin Expansion Narrative
Azenta (AZTA) Stock Could Be Undervalued Even With Legal Scrutiny
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.